Verastem | VSTM - Bienes





Bienes Cambio Fecha
AbbVie USD 133.96B 62M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
AstraZeneca USD 114.07B 382M 2025-12
Curis USD 29.23M 10.09M 2025-06
Cytokinetics USD 1.42B 12.02M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
TG Therapeutics USD 1.06B 38.23M 2025-12
Verastem USD 176.85M 45.15M 2025-09